Related Experiment Video

Updated: Jul 13, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Sturge-Weber syndrome and epilepsy: an argument for aggressive seizure management in these patients

Anne M Comi1

  • 1Department of Neurology, Kennedy Krieger Institute & Johns Hopkins Medicine, Baltimore, MD, USA. comi@kennedykrieger.org

Expert Review of Neurotherapeutics
|August 7, 2007
PubMed

Insights

Sturge-Weber syndrome (SWS) causes facial port-wine stains and can lead to brain and eye issues. Early diagnosis and research into SWS neuropathology are crucial for managing seizures and neurologic deficits.

Area of Science:

  • Neurology
  • Medical Genetics
  • Pediatrics

Background:

  • Sturge-Weber syndrome (SWS) is a rare congenital disorder characterized by vascular malformations affecting the skin, eyes, and brain.
  • Facial port-wine stains, particularly on the upper face, are associated with increased risk of intracranial leptomeningeal angiomas and neurological complications.
  • Affected infants and children frequently experience seizures and progressive neurological impairments.

Purpose of the Study:

  • To review the clinical manifestations, diagnostic challenges, and management controversies in Sturge-Weber syndrome.
  • To highlight the role of cerebral perfusion impairments and seizures in SWS neuropathology.
  • To advocate for the development of a multicentered clinical trial network for SWS.

Main Methods:

  • Review of existing literature on Sturge-Weber syndrome.
  • Analysis of clinical course and functional imaging findings in SWS patients.
  • Discussion of diagnostic imaging modalities (CT, MRI) and their limitations in early diagnosis.

Main Results:

  • Seizures affect over 75% of individuals with SWS.
  • Neurologic deficits can progress variably, influenced by both perfusion impairments and seizure activity.
  • Current diagnostic imaging sensitivity is limited in young, asymptomatic infants.

Conclusions:

  • Further research is essential to understand the etiology and molecular neuropathology of SWS.
  • Establishing a multicentered network is critical for conducting effective clinical trials in SWS.
  • Addressing management controversies and improving early diagnosis are key priorities for SWS patient care.

More Related Videos

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring11:28

Robotic-Guided Stereoelectroencephalography for Invasive Epilepsy Monitoring

Published on: June 13, 2025

Stereo-Electro-Encephalo-Graphy (SEEG) With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note05:54

Stereo-Electro-Encephalo-Graphy (SEEG) With Robotic Assistance in the Presurgical Evaluation of Medical Refractory Epilepsy: A Technical Note

Published on: June 13, 2016

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...